Core Insights - Cabot Corporation's Q4 fiscal 2025 earnings were significantly lower than the previous year, with reported earnings of 79 cents per share compared to $2.43 in the same quarter last year, and adjusted earnings of $1.70 per share, missing the Zacks Consensus Estimate of $1.72 [2][3] Financial Performance - The company's net sales for Q4 were $899 million, falling short of the Zacks Consensus Estimate of $952.6 million, and representing a decline of approximately 10.2% year-over-year [3] - In the Reinforcement Materials segment, sales decreased by around 12.6% year-over-year to $563 million, missing the consensus estimate of $617 million, with EBIT down 3.3% to $119 million due to lower volumes in Asia Pacific and the Americas [4] - The Performance Chemicals division saw a sales decline of 4.3% year-over-year to $308 million, also missing the consensus estimate of $313 million, with EBIT decreasing approximately 4.6% to $42 million, primarily due to a 5% decrease in volumes driven by reduced demand in Europe [5] Financial Position - At the end of Q4, Cabot had a cash balance of $258 million, with cash flows from operating activities amounting to $219 million and capital expenditures totaling $64 million [6] Outlook - The company does not expect a recovery in the external environment for fiscal 2026, particularly in the Reinforcement Materials segment, and anticipates adjusted EPS for the fiscal year to range between $6.00 and $7.00 [7] - Performance Chemicals is expected to deliver profit growth, supported by strength in Battery Materials and opportunities in infrastructure and alternative energy [7] - Since the earnings release, there has been a downward trend in estimates, with the consensus estimate shifting down by 28.98% [8] Industry Context - Cabot is part of the Zacks Chemical - Diversified industry, where Methanex, a peer, reported revenues of $927 million for the quarter ended September 2025, reflecting a year-over-year change of -0.9% [12] - Methanex's expected earnings for the current quarter are $0.87 per share, indicating a change of -29.8% from the year-ago quarter, with a Zacks Rank of 3 (Hold) [13]
Cabot (CBT) Up 4.4% Since Last Earnings Report: Can It Continue?